Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Study of the Effect of Fibrinogen, Factor XIII and Recombinant Activated Factor VII in a Model of Trauma-Induced Coagulopathy

Manuel Quintana, MD PhD, Kapil Nanwani, MD PhD, Charbel Maroun, MD PhD, Elena Elena Muñoz, MD, Ana María Martínez, MD PhD, Mar Gutierrez, MD, Elena G Arias-Salgado, PhD, Dolores Hernández-Maraver, MD, Ana Kerguelen Fuentes, MD PhD, Rosario Torres, MD, Miguel A Canales, MD PhD, Aurora Viejo, MD, Nora V. Butta, PhD, María Teresa Alvarez Román, MD PhD, Víctor Jiménez-Yuste, MD PhD

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-142482

Published: 2020

Journal Articles

Multicentric, Retrospective Study of Extracorporeal Photopheresis, Off-Line System, in Corticosteroid Refractory Acute and Chronic Graft-Versus-Host Disease

Gillen Oarbeascoa, MD, Maria Luisa Lozano, MD PhD, Luisa Maria Guerra, MD, Cristina Amunarriz, MD, Nuria Revilla, MD, Iniesta Pastora, MD, Cynthia Acosta Fleitas, MD, Jose Luis Arroyo, MD, Eva Martinez Revuelta, MD, Andrea Galego, MD, Dolores Hernandez-Maraver, PhD, Mi Kwon, Jose Luis Díez-Martín, MD PhD, Aurora Viejo, MD, Jose Maria Garcia-Gala, MD, Concepcion Andon Saavedra, Cristina Pascual, MD PhD, (GEA) Grupo Español de Aferesis

Blood (2018) 132 (Supplement 1): 3405.

https://doi.org/10.1182/blood-2018-99-118608

Published: 2018

Journal Articles

Consideration of Symptom Burden Based Treatment in PV and ET Patients: An Analysis By MPN International Quality of Life Study Group

Robyn M. Scherber, MD MPH, Holly Geyer, MD, Heidi E. Kosiorek, MS, Amylou C. Dueck, PhD, Jean-Jacques Kiladjian, MD PhD, Stefanie Slot, Sonja Zweegman, MD PhD, Peter Te Boekhorst, Suzan Commandeur, MSc, Harry C. Schouten, Federico Sackmann, MD, Ana Kerguelen Fuentes, Dolores Hernandez-Maraver, PhD, Heike L Pahl, PhD, Martin Griesshammer, MD, Frank Stegelmann, MD, Konstanze Doehner, MD, Thomas Lehmann, Karen Bonatz, Andreas Reiter, MD, Francoise Boyer, MD, Gabriel Etienne, MD PhD, Jean Christophe Ianotto, Dana Ranta, MD, Lydia Roy, MD, Jean-Yves Cahn, MD, Claire N. Harrison, DM, FRCP, FRCPath, Deepti Radia, MBBS, MRCPI, FRCPath MSc, MD, Pablo J. Muxi, MD, Norman I Maldonado, MD, Carlos Besses, MD PhD, Francisco Cervantes, MD PhD, Peter L. Johansson, MD PhD, Tiziano Barbui, MD, Giovanni Barosi, Alessandro M. Vannucchi, MD, Francesco Passamonti, MD, Bjorn Andreasson, Maria Ferrari, Alessandro Rambaldi, MD, Jan Samuelsson, MD PhD, Keith Cannon, MD, Xiujuan Sun, MD, Junqing Xu, Peihong Zhang, Zefeng Xu, Ruben A. Mesa, MD

Blood (2016) 128 (22): 5463.

https://doi.org/10.1182/blood.V128.22.5463.5463

Published: 2016

Journal Articles

Symptom Burden As Primary Driver for Therapy in Patients with Myelofibrosis: An Analysis By MPN International Quality of Life Study Group

Robyn M. Scherber, MD MPH, Holly Geyer, MD, Amylou Constance Dueck, PhD, Heidi E. Kosiorek, MS, Jean-Jacques Kiladjian, MD PhD, Stefanie Slot, Sonja Zweegman, MD PhD, Peter Te Boekhorst, Suzan Commandeur, MSc, Harry C. Schouten, Federico Sackmann, MD, Ana Kerguelen Fuentes, MD, Dolores Hernandez-Maraver, PhD, Heike L Pahl, PhD, Martin Griesshammer, MD, Frank Stegelmann, MD, Konstanze Doehner, MD, Thomas Lehmann, Karen Bonatz, Andreas Reiter, MD, Francoise Boyer, MD, Gabriel Etienne, MD PhD, Jean Christophe Ianotto, Dana Ranta, MD, Lydia Roy, MD, Jean-Yves Cahn, MD, Claire N. Harrison, DM, FRCP, FRCPath, Deepti Radia, MBBS, MRCPI, FRCPath MSc, MD, Pablo J. Muxi, MD, Norman I Maldonado, MD, Carlos Besses, MD PhD, Francisco Cervantes, MD PhD, Peter L. Johansson, MD PhD, Tiziano Barbui, MD, Giovanni Barosi, Alessandro M. Vannucchi, MD, Bjorn Andreasson, Maria Ferarri, Alessandro Rambaldi, MD, Jan Samuelsson, MD PhD, Gunnar Birgegard, MD PhD, Keith Cannon, MD, Xuijuan Sun, Junqing Xu, Peihong Zhang, Zefeng Xu, Ruben A. Mesa, MD

Blood (2016) 128 (22): 3117.

https://doi.org/10.1182/blood.V128.22.3117.3117

Published: 2016

Journal Articles

Unmet Needs for Symptom Control in Essential Thrombocythemia with Front Line Therapy

Holly Geyer, MD, Robyn M. Scherber, MD MPH, Heidi Kosiorek, M.S., Amylou C. Dueck, PhD, Jean-Jacques Kiladjian, MD PhD, Stefanie Slot, Zhijian Xiao, DO, Sonja Zweegman, MD PhD, Federico Sackmann, Ana Kerguelen Fuentes, Dolores Hernandez-Maraver, PhD, Konstanze Döhner, MD, Claire N. Harrison, Deepti Radia, Pablo J. Muxi, MD, Carlos Besses, Francisco Cervantes, Peter L. Johansson, MD PhD, Bjorn Andreasson, MDPhD, Alessandro Rambaldi, MD, Tiziano Barbui, MD, Karin Bonatz, Andreas Reiter, MD, Francoise Boyer, MD, Gabriel Etienne, MD PhD, Jean-Christophe Ianotto, MD, Dana Ranta, Lydia Roy, MD, Jean-Yves Cahn, Norman I Maldonado, MD, Giovanni Barosi, MD, Maria Ferrari, Robert Peter Gale, MD PhD DSc, Gunnar Birgegard, MD PhD, Zefeng Xu, MD, Yu Zhang, B.S., Xiujuan Sun, MD, Junqing Xu, Peihong Zhang, Peter A. te Boekhorst, Suzan Commandeur, Harry C. Schouten, MD PhD, Heike L Pahl, PhD, Martin Griesshammer, MD, Frank Stegelmann, MD, Thomas Lehmann, Alessandro M. Vannucchi, MD, Francesco Passamonti, MD, Jan Samuelsson, MD PhD, Ruben A. Mesa, MD

Blood (2015) 126 (23): 5175.

https://doi.org/10.1182/blood.V126.23.5175.5175

Published: 2015

Journal Articles

Impact of Disease Duration upon Symptom Burden Amongst Patients with Myeloproliferative Neoplasms (MPNs)

Robyn M. Scherber, MD MPH, Holly Geyer, MD, Claire N. Harrison, Heidi E. Kosiorek, MS, Amylou C. Dueck, PhD, Jean-Jacques Kiladjian, MD PhD, Stefanie Slot, Zhijian Xiao, DO, Sonja Zweegman, MD PhD, Federico Sackmann, Ana Kerguelen Fuentes, Dolores Hernandez-Maraver, PhD, Konstanze Döhner, MD, Deepti Radia, Pablo J. Muxi, MD, Carlos Besses, Francisco Cervantes, MD PhD, Peter L. Johansson, MD PhD, Bjorn Andreasson, MDPhD, Alessandro Rambaldi, MD, Tiziano Barbui, MD, Karin Bonatz, Andreas Reiter, MD, Francoise Boyer, MD, Gabriel Etienne, MD PhD, Jean-Christophe Ianotto, Dana Ranta, Jean Roy, MD, Jean-Yves Cahn, Norman I Maldonado, MD, Giovanni Barosi, MD, Maria Ferrari, Robert Peter Gale, MD PhD DSc, Gunnar Birgegard, MD PhD, Zefeng Xu, MD, Yu Zhang, B.S., Xiujuan Sun, MD, Junqing Xu, Peihong Zhang, Peter A. te Boekhorst, Suzan Commandeur, Harry C. Schouten, MD PhD, Heike L Pahl, PhD, Martin Griesshammer, MD, Frank Stegelmann, MD, Thomas Lehmann, Alessandro M. Vannucchi, MD, Francesco Passamonti, MD, Jan Samuelsson, MD PhD, Ruben A. Mesa, MD

Blood (2015) 126 (23): 4073.

https://doi.org/10.1182/blood.V126.23.4073.4073

Published: 2015

Journal Articles

Symptom Burden Profile in Myelofibrosis Patients with Thrombocytopenia: Lessons and Unmet Needs

Holly Geyer, MD, Robyn M Scherber, MD MPH, Heidi Kosiorek, Amylou C. Dueck, PhD, Jean-Jacques Kiladjian, MD PhD, Zhijian Xiao, MD, Stefanie Slot, Sonja Zweegman, MD PhD, Federico Sackmann, Ana Kerguelen Fuentes, Dolores Hernandez-Maraver, PhD, Konstanze Dohner, MD, Claire N. Harrison, Deepti Radia, Pablo J. Muxi, MD, Carlos Besses, Francisco Cervantes, Peter L. Johansson, MD PhD, Bjorn Andreasson, MDPhD, Alessandro Rambaldi, MD, Tiziano Barbui, MD, Karin Bonatz, Andreas Reiter, MD, Francoise Boyer, MD, Gabriel Etienne, MD PhD, Jean-Christophe Ianotto, MD, Dana Ranta, Lydia Roy, MD, Jean-Yves Cahn, Norman I Maldonado, MD, Giovanni Barosi, Maria Ferrari, Robert Peter Gale, MD PhD DSc, Gunnar Birgegard, MD PhD, Zefeng Xu, MD, Yue Zhang, MD, Xiujuan Sun, MD, Junqing Xu, Peihong Zhang, Peter te Boekhorst, Suzan Commandeur, Harry C. Schouten, MD PhD, Heike L Pahl, PhD, Martin Griesshammer, MD, Frank Stegelmann, MD, Thomas Lehmann, Alessandro M. Vannucchi, Francesco Passamonti, MD, Jan Samuelsson, MD PhD, Ruben A. Mesa, MD

Blood (2015) 126 (23): 4080.

https://doi.org/10.1182/blood.V126.23.4080.4080

Published: 2015

Journal Articles

Kinetics of Response to Bortezomib/Thalidomide/Dexamethasone (VTD) in Multiple Myeloma: Implications for the Choice and Design of Pretransplantation Induction Regimens

Blood (2014) 124 (21): 2108.

https://doi.org/10.1182/blood.V124.21.2108.2108

Published: 2014

Journal Articles

Symptom Severity and Clinical Variables of Polycythemia Vera Patients with Splenomegaly, Phlebotomy Requirements and/or Hydroxyurea Use: a Retrospective Evaluation of 1334 Patients

Holly Lynn Geyer, MD, Robyn M Scherber, MD MPH, Amylou Constance Dueck, PhD, Jean-Jacques Kiladjian, MD PhD, Zhijian Xiao, MD, Stephanie Slot, BSc, Sonja Zweegman, MDPhD, Ana Kerguelen Fuentes, Dolores Hernández-Maraver, MD PhD, Konstanze Dohner, MD, Claire N. Harrison, DM, FRCP, FRCPath, Deepti H Radia, MDFRCPath MSc MDEd, Pablo J. Muxi, MD, Federico Sackman, Carlos Besses, Francisco Cervantes, MD PhD, Peter L. Johansson, MD PhD, Bjorn Andreasson, MD, Alessandro Rambaldi, MD, Tiziano Barbui, MD, Alessandro M. Vannucchi, MD, Francesco Passamonti, MD, Jan Samuelsson, MD PhD, Gunnar Birgegard, Karin Bonatz, MD, Andreas Reiter, MD, Françoise Boyer, MD, Gabriel Etienne, MD PhD, Jean-Christophe Ianotto, MD, Dana Ranta, MD, Lydia Roy, MD, Jean-Yves Cahn, Norman I Maldonado, MD, Giovanni Barosi, MD, Maria Ferrari, MD, Keith Cannon, MD, Peter te Boekhorst, MD PhD, Harry C Schouten, MDPhD, Heike L. Pahl, PhD, Martin Griesshammer, Frank Stegelmann, MD, Thomas Lehmann, MD, Zefeng Xu, MD, Yue Zhang, Xiujuan Sun, Junqing Xu, Peihong Zhang, Ruben Mesa, MD

Blood (2014) 124 (21): 1848.

https://doi.org/10.1182/blood.V124.21.1848.1848

Published: 2014

Journal Articles

Persistent Benefit of VTD (Bortezomib/Thalidomide/Dexamethasone) As Pretransplant Induction Therapy for Multiple Myeloma: Long-Term Follow-up of a Randomized Phase 3 Pethema/GEM Study

Blood (2014) 124 (21): 3457.

https://doi.org/10.1182/blood.V124.21.3457.3457

Published: 2014

Journal Articles

Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients

Blood (2014) 123 (24): 3803–3810.

https://doi.org/10.1182/blood-2013-09-527903

Published: 2014

Includes: Supplemental data

Journal Articles

Characteristics and Outcome Of 66 Patients With Extramedullary Plasmacytomas (EMPs) Included In a Phase III Pethema/GEM Study Of Induction Therapy Prior Autologous Stem Cell Transplantation (ASCT) In Multiple Myeloma (MM)

Laura Rosiñol, MD, Raquel Jiménez-Segura, Ana Isabel Teruel, MD, Javier De La Rubia, MD, PhD, Maria Victoria Mateos, MD, PhD, Miguel T. Hernandez, Dolores Hernández, M Jesús Blanchard, Belén Iñigo, Luis Palomera, MD, Isabel Krsnik, MD, PhD, Jose Francisco Tomas, MD, Norma C. Gutiérrez, Jesús F. San Miguel, MD, PhD, Juan José Lahuerta, Joan Blade, MD

Blood (2013) 122 (21): 3188.

https://doi.org/10.1182/blood.V122.21.3188.3188

Published: 2013

Journal Articles

Myeloproliferative (MPN) Symptom Burden Response Thresholds: Assessment Of MPN-SAF TSS Quartiles As Potential Markers Of Symptom Response

Robyn M. Emanuel, MD, MPH, Amylou Constance Dueck, PhD, Holly Lynn Geyer, MD, Jean-Jacques Kiladjian, MD, PhD, Stephanie Slot, BSc, Sonja Zweegman, MD PhD, Peter te Boekhorst, MD, PhD, Suzan Commandeur, PhD, Harry C. Schouten, MD, PhD, Federico Sackmann, MD, Dolores Hernandez, MD, Ana Kerguelen Fuentes, Heike L. Pahl, PhD, Frank Stegelmann, MD, Konstanze Doehner, MD, Thomas Lehmann, MD, Karin Bonatz, MD, Andreas Reiter, MD, Françoise Boyer, Gabriel Etienne, MD, PHD, Jean-Christophe Ianotto, MD, Dana Ranta, MD, Lydia Roy, MD, Jean-Yves Cahn, MD, PhD, Claire N Harrison, DM, FRCP, FRCPath, Deepti H Radia, MD FRCPath MSc Med Ed, Pablo J. Muxi, MD, Norman I Maldonado, MD, Carlos Besses, MD, PhD, Francisco Cervantes, MD, PhD, Peter Johansson, MD, PhD, Tiziano Barbui, MD, Giovanni Barosi, MD, Alessandro M Vannucchi, MD, Francesco Passamonti, MD, Bjorn Andreasson, MD, Maria Ferrari, MD, Martin Griesshammer, MD, PhD, Alessandro Rambaldi, MD, Jan Samuelsson, MD, Gunnar Birgegard, MD, PhD, Zhijian Xiao, MD, Zefeng Xu, Yue Zhang, Xiujuan Sun, Junqing Xu, Peihong Zhang, Robert Peter Gale, MD, PhD, DSc, FACP, Ayalew Tefferi, MD, Ruben A. Mesa, MD

Blood (2013) 122 (21): 4067.

https://doi.org/10.1182/blood.V122.21.4067.4067

Published: 2013

Journal Articles

Insomnia, Quality Of Life and MPN Symptom Burden: An Analysis By The MPN Quality Of Life International Study Group (MPN-QOL ISG)

Holly Lynn Geyer, MD, Amylou Constance Dueck, PhD, Robyn M. Emanuel, MD, MPH, Keith Cannon, MD, Jean-Jacques Kiladjian, MD, PhD, Stephanie Slot, BSc, Sonja Zweegman, MD PhD, Peter Boekhorst, Suzan Commandeur, PhD, Harry C. Schouten, MD, PhD, Federico Sackmann, MD, Ana Kerguelen Fuentes, Dolores Hernández-Maraver, MD, PhD, Heike L. Pahl, PhD, Martin Griesshammer, MD, PhD, Frank Stegelmann, MD, Konstanze Dohner, M.D., Thomas Lehmann, MD, Karin Bonatz, MD, Andreas Reiter, MD, Françoise Boyer, Gabriel Etienne, MD, PHD, Jean-Christophe Ianotto, MD, Dana Ranta, MD, Lydia Roy, MD, Jean-Yves Cahn, MD, Claire N Harrison, DM, FRCP, FRCPath, Deepti H Radia, MD FRCPath MSc Med Ed, Pablo J. Muxi, MD, Norman I Maldonado, MD, Carlos Besses, Francisco Cervantes, MD, PhD, Peter Johansson, MD, PhD, Tiziano Barbui, MD, Giovanni Barosi, MD, Alessandro M. Vannucchi, MD, Francesco Passamonti, Bjorn Andreasson, MD, Maria Ferrari, MD, Alessandro Rambaldi, MD, Jan Samuelsson, MD, Gunnar Birgegard, MD, PhD, Zhijian Xiao, MD, Zefeng Xu, Yue Zhang, Xiujuan Sun, Junqing Xu, Peihong Zhang, Robert Peter Peter Gale, MD, PhD, DSc, Ruben A. Mesa, MD

Blood (2013) 122 (21): 4087.

https://doi.org/10.1182/blood.V122.21.4087.4087

Published: 2013

Journal Articles

Sexuality Challenges, Intimacy, and MPN Symptom Burden: An Analysis By The MPN Quality Of Life International Study Group (MPN-QOL ISG)

Holly Lynn Geyer, MD, Amylou C. Dueck, PhD, Robyn M. Emanuel, MD, MPH, Keith Cannon, MD, Jean-Jacques Kiladjian, MD, PhD, Stephanie Slot, BSc, Sonja Zweegman, MD PhD, Peter Boekhorst, Suzan Commandeur, PhD, Harry C. Schouten, MD, PhD, Federico Sackmann, MD, Ana Kerguelen Fuentes, Dolores Hernandez, MD, Heike L. Pahl, PhD, Martin Griesshammer, MD, PhD, Frank Stegelmann, MD, Konstanze Döhner, MD, Thomas Lehmann, MD, Dana Ranta, MD, Andreas Reiter, MD, Françoise Boyer, Gabriel Etienne, MD, PHD, Jean-Christophe Ianotto, MD, Lydia Roy, MD, Jean-Yves Cahn, MD, Claire N Harrison, DM, FRCP, FRCPath, Deepti H Radia, MD FRCPath MSc Med Ed, Pablo J. Muxi, MD, Norman I Maldonado, MD, Carlos Besses, Francisco Cervantes, MD, PhD, Peter Johansson, MD, PhD, Tiziano Barbui, MD, Giovanni Barosi, MD, Alessandro M Vannucchi, MD, Francesco Passamonti, Bjorn Andreasson, MD, Maria Ferrari, MD, Alessandro Rambaldi, Jan Samuelsson, MD, Gunnar Birgegard, MD, PhD, Zhijian Xiao, MD, Zefeng Xu, Xiujuan Sun, Junqing Xu, Peihong Zhang, Robert Peter Gale, MD, PhD, DSc, FACP, Ruben A Mesa, MD

Blood (2013) 122 (21): 4088.

https://doi.org/10.1182/blood.V122.21.4088.4088

Published: 2013

Journal Articles

The Myelofibrosis Symptom Burden (MF-SB): An International Phenotypic Cluster Analysis of 329 Patients

Holly Lynn Geyer, MD, Amylou C. Dueck, PhD, Robyn M. Emanuel, MD, MPH, Jean-Jacques Kiladjian, MD, PhD, Stefanie Slot, Sonja Zweegman, MD, PhD, Peter Boekhorst, Suzan Commandeur, MSc, Harry C Schouten, MD, PhD, Federico Sackmann, Ana Kerguelen Fuentes, MD, Dolores Hernandez-Maraver, Heike Pahl, Martin Griesshammer, Frank Stegelmann, MD, Konstanze Doehner, Françoise Boyer, Gabriel Etienne, MD, PHD, Jean-Christophe Lanotto, Dana Ranta, MD, Lydia Roy, MD, Jean-Yves Cahn, MD, PhD, Claire N Harrison, DM FRCP FRCPath, Deepti H Radia, MD FRCPath MSc Med Ed, Pablo J. Muxi, MD, Norman I. Maldonado, MD, Carlos Besses, MD, PhD, Francisco Cervantes, MD, PhD, Peter Johansson, MD, PhD, Giovanni Barosi, MD, Alessandro M. Vannucchi, MD, Francesco Passamonti, MD, Bjorn Andreasson, MD, Maria L Ferarri, MD, Alessandro Rambaldi, MD, Jan Samuelsson, MD, Gunnar Birgegard, MD, PhD, Zhijian Xiao, MD, Yue Zhang, Xiujuan Sun, Junqing Xu, Robert Peter Gale, Ayalew Tefferi, MD, Peihong Zhang, Thomas Lehmann, MD, Andreas Reiter, MD, Karin Bonatz, Ruben A. Mesa

Blood (2012) 120 (21): 1731.

https://doi.org/10.1182/blood.V120.21.1731.1731

Published: 2012

Journal Articles

Phase II Optimization, Open-Label Clinical Trial of Zalypsis ® (PM00104) in Relapsed/Refractory Multiple Myeloma Patients

Enrique M Ocio, MD, PhD, Javier De La Rubia, MD, Albert Oriol-Rocafiguera, MD, Joan Blade, MD, Jose Rodriguez, MD, Cinthya Coronado, MD, Jesus Martin Sanchez, MD, Ana Isabel Teruel, MD, Dolores Hernandez-Maraver, MD, Felipe Prosper, MD, Jesus. F San-Miguel, MD

Blood (2012) 120 (21): 4041.

https://doi.org/10.1182/blood.V120.21.4041.4041

Published: 2012

Journal Articles

Essential Thrombocythemia (ET) and Polycythemia Vera (PV) Symptom Burden: Phenotypic Cluster Analysis Among an International Sample of 1,141 ET and PV Patients

Robyn M. Emanuel, MD, MPH, Amylou C. Dueck, PhD, Holly Lynn Geyer, MD, Jean-Jacques Kiladjian, MD, PhD, Stefanie Slot, BSc, Sonja Zweegman, MD, PhD, Peter te Boekhorst, MD, PhD, Suzan Commandeur, MSc, Harry C Schouten, MD, PhD, Federico Sackmann, MD, Ana Kerguelen Fuentes, Dolores Hernandez, MD, Heike L. Pahl, PhD, Martin Griesshammer, MD, Frank Stegelmann, MD, Konstanze Doehner, Thomas Lehmann, MD, Karin Bonatz, MD, Andreas Reiter, MD, Françoise Boyer, Gabriel Etienne, MD, PHD, Jean-Christophe Ianotto, MD, Dana Ranta, MD, Lydia Roy, MD, Jean-Yves Cahn, MD, Claire N Harrison, DM FRCP FRCPath, Deepti H Radia, MD FRCPath MSc Med Ed, Pablo J. Muxi, MD, Norman I Maldonado, MD, Carlos Besses, MD, PhD, Francisco Cervantes, MD, PhD, Peter Johansson, MD, PhD, Tiziano Barbui, MD, Giovanni Barosi, MD, Alessandro M. Vannucchi, MD, Francesco Passamonti, MD, Bjorn Andreasson, MD, Maria L Ferarri, MD, Alessandro Rambaldi, MD, Gunnar Birgegard, MD, PhD, Zhijian Xiao, MD, Zefeng Xu, Yue Zhang, Xiujuan Sun, Junqing Xu, Peihong Zhang, Robert Peter Gale, MD, PhD, DSc, Ayalew Tefferi, MD, Ruben A. Mesa

Blood (2012) 120 (21): 1726.

https://doi.org/10.1182/blood.V120.21.1726.1726

Published: 2012

Journal Articles

Comparison of the Myleloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) Across Nine Linguistic Translations Among an International Sample of 1,851 Myeloproliferative Neoplasm (MPN) Patients.

Amylou Constance Dueck, PhD, Robyn M. Emanuel, MD, MPH, Holly Lynn Geyer, MD, Jean-Jacques Kiladjian, MD, PhD, Stephanie Slot, BSc, Sonja Zweegman, MD, PhD, Peter te Boekhorst, MD, PhD, Suzan Commandeur, MSc, Harry C Schouten, MD, PhD, Federico Sackmann, MD, Ana Kerguelen Fuentes, Dolores Hernandez, MD, Heike L. Pahl, PhD, Martin Griesshammer, MD, PhD, Frank Stegelmann, MD, Konstanze Doehner, Thomas Lehmann, MD, Karin Bonatz, MD, Andreas Reiter, MD, Françoise Boyer, MD, Gabriel Etienne, MD, PHD, Jean-Christophe Ianotto, MD, Dana Ranta, MD, Lydia Roy, MD, Jean-Yves Cahn, MD, Claire N Harrison, DM FRCP FRCPath, Deepti H Radia, MD FRCPath MSc Med Ed, Pablo J. Muxi, MD, Norman I Maldonado, MD, Carlos Besses, MD, PhD, Francisco Cervantes, MD, PhD, Peter Johansson, MD, PhD, Tiziano Barbui, MD, Giovanni Barosi, MD, Alessandro M. Vannucchi, MD, Francesco Passamonti, MD, Bjorn Andreasson, MD, Maria L Ferarri, MD, Alessandro Rambaldi, MD, Jan Samuelsson, MD, Gunnar Birgegard, MD, PhD, Ayalew Tefferi, MD, Zhijian Xiao, MD, Zefeng Xu, Yue Zhang, Xiujuan Sun, Junqing Xu, Peihong Zhang, Robert Peter Gale, Ruben A. Mesa

Blood (2012) 120 (21): 2852.

https://doi.org/10.1182/blood.V120.21.2852.2852

Published: 2012

Journal Articles

Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study

Blood (2012) 120 (8): 1589–1596.

https://doi.org/10.1182/blood-2012-02-408922

Published: 2012

Includes: Supplemental data

NARROW

Study of the Effect of Fibrinogen, Factor XIII and Recombinant Activated Factor VII in a Model of Trauma-Induced Coagulopathy

Multicentric, Retrospective Study of Extracorporeal Photopheresis, Off-Line System, in Corticosteroid Refractory Acute and Chronic Graft-Versus-Host Disease

Consideration of Symptom Burden Based Treatment in PV and ET Patients: An Analysis By MPN International Quality of Life Study Group

Symptom Burden As Primary Driver for Therapy in Patients with Myelofibrosis: An Analysis By MPN International Quality of Life Study Group

Unmet Needs for Symptom Control in Essential Thrombocythemia with Front Line Therapy

Impact of Disease Duration upon Symptom Burden Amongst Patients with Myeloproliferative Neoplasms (MPNs)

Symptom Burden Profile in Myelofibrosis Patients with Thrombocytopenia: Lessons and Unmet Needs

Kinetics of Response to Bortezomib/Thalidomide/Dexamethasone (VTD) in Multiple Myeloma: Implications for the Choice and Design of Pretransplantation Induction Regimens

Symptom Severity and Clinical Variables of Polycythemia Vera Patients with Splenomegaly, Phlebotomy Requirements and/or Hydroxyurea Use: a Retrospective Evaluation of 1334 Patients

Persistent Benefit of VTD (Bortezomib/Thalidomide/Dexamethasone) As Pretransplant Induction Therapy for Multiple Myeloma: Long-Term Follow-up of a Randomized Phase 3 Pethema/GEM Study

Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients

Characteristics and Outcome Of 66 Patients With Extramedullary Plasmacytomas (EMPs) Included In a Phase III Pethema/GEM Study Of Induction Therapy Prior Autologous Stem Cell Transplantation (ASCT) In Multiple Myeloma (MM)

Myeloproliferative (MPN) Symptom Burden Response Thresholds: Assessment Of MPN-SAF TSS Quartiles As Potential Markers Of Symptom Response

Insomnia, Quality Of Life and MPN Symptom Burden: An Analysis By The MPN Quality Of Life International Study Group (MPN-QOL ISG)

Sexuality Challenges, Intimacy, and MPN Symptom Burden: An Analysis By The MPN Quality Of Life International Study Group (MPN-QOL ISG)

The Myelofibrosis Symptom Burden (MF-SB): An International Phenotypic Cluster Analysis of 329 Patients

Phase II Optimization, Open-Label Clinical Trial of Zalypsis ® (PM00104) in Relapsed/Refractory Multiple Myeloma Patients

Essential Thrombocythemia (ET) and Polycythemia Vera (PV) Symptom Burden: Phenotypic Cluster Analysis Among an International Sample of 1,141 ET and PV Patients

Comparison of the Myleloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) Across Nine Linguistic Translations Among an International Sample of 1,851 Myeloproliferative Neoplasm (MPN) Patients.

Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only